Sartorius Stedim Biotech S.A.
SDMHF
$235.80
$0.800.34%
OTC PK
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -43.54% | -61.82% | -72.12% | |
| Total Depreciation and Amortization | -- | 21.69% | 23.61% | 49.75% | |
| Total Amortization of Deferred Charges | -- | 77.05% | 28.18% | 28.18% | |
| Total Other Non-Cash Items | -- | 1,009.17% | 359.61% | 171.12% | |
| Change in Net Operating Assets | -- | 31.70% | 7,950.45% | 430.63% | |
| Cash from Operations | -- | 9.31% | 40.46% | 7.99% | |
| Capital Expenditure | -- | 28.27% | 28.13% | 19.29% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | 100.00% | -383.91% | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 97.60% | 85.53% | 22.27% | |
| Cash from Investing | -- | 87.58% | 86.81% | -172.59% | |
| Total Debt Issued | -- | -99.35% | -99.49% | 275.32% | |
| Total Debt Repaid | -- | -169.36% | -255.37% | -1,432.54% | |
| Issuance of Common Stock | -- | 35,123.53% | 59,730.00% | 34,045.71% | |
| Repurchase of Common Stock | -- | -180.95% | -180.95% | -180.95% | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | 49.25% | 49.25% | 49.25% | |
| Other Financing Activities | -- | 13.40% | -82.07% | 4.49% | |
| Cash from Financing | -- | -95.67% | -105.44% | 734.92% | |
| Foreign Exchange rate Adjustments | -- | 814.27% | 91.74% | -6,379.23% | |
| Miscellaneous Cash Flow Adjustments | -- | -0.28% | -0.28% | -0.28% | |
| Net Change in Cash | -- | 5,728.80% | 984.84% | 907.02% | |